is wegovy a glp 1 drug GLP-1 weight loss drugs may be misused by patients with eating disorders: Study Oksana Aron, M.D., Medical Weight
Description
What the published research reported A phase-2 randomized trial published in the New England Journal of Medicine in 2023 studied retatrutide in adults with obesity and reported substantial, dose-dependent reductions in body weight over 48 weeks, alongside a gastrointestinal side-effect profile broadly similar to other incretin drugs
10.7% with placebo, diarrhea (34.7% and 33.1%) vs
What Science Says Last Updated: Nov 13, 2025
Inflammation in Parkinsons Disease: Mechanisms and Therapeutic Implications
In MPTP-induced PD models, liraglutide treatment reduced the levels of neuroinflammatory markers in the substantia nigra through AMPK activation and NF-B reduction [88]
Program of Shanghai Academic/Technology Research Leader (23XD1400900 to D.Y.) and Shanghai Sailing Program (22YF1457200 to F.Z.)
